Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

277.26 USD UNCHANGED
Streaming Delayed Price Updated: 8:22 AM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2
...
89 90 91 92 93 94 95 96 97
...
99 100 Next >
Biogen shares soar on reports of possible takeover from Merck, Allergan
Biogen shares soared on reports the company has drawn takeover interest from drug companies Merck and Allergan, the Wall Street Journal reported. 
Tags Biogen Inc Investing
From CNBC.com News
Merck and Allergan have both expressed interest in a Biogen takeover
The rival drugmakers have both sussed out the possibility of a takeover. 
Tags Medical Products BIIB Company Announcements/Warnings
From MarketWatch
The $75 billion biotech giant Biogen is surging on a report of a potential takeover (BIIB)
Tags Wall Street, biogen, Mergers And Acquisitions, Deals, Pharmaceuticals, Biotech, BIIB
From Business Insider
BRIEF-Biogen has drawn takeover interest from drug companies including Merck & Co and Allergan - WSJ
* Biogen has drawn takeover interest from drug companies including Merck & Co and Allergan Plc- WSJ, citing sources Source (http://on.wsj.com/2b0s6q9) (Bengaluru Newsroom: +1-646-223-8780) 
Tags companyNews
From Reuters: Company News
Oil Narrowly Averts a Death Cross
 
Tags INDEXRUSSELL:RUT NASDAQ:TSLA NYSE:DO
From InvestorPlace
Biogen, JC Penney And More: Fast Money Picks For August 2
On CNBC's Fast Money Final Trade, Pete Najarian said he noticed unusually high options activity in Bristol-Myers Squibb Co (NYSE: ... 
Tags Media David Seaburg BIIB
From Benzinga
Ionis Pharma CEO: Nusinersen an 'enormous commercial opportunity'
Jim Cramer spoke with the CEO of Ionis Pharmaceuticals, which skyrocketed on Monday following positive data for its spinal muscular atrophy drug. 
Tags Ionis Pharmaceuticals Inc Biogen Inc Mad Money
From CNBC.com News
Positive trial results for Ionis
Ionis Pharmaceuticals Inc. (Nasdaq: IONS) reported positive results from a late-stage clinical trial of nusinersen to treat infants with spinal muscular atrophy which triggered a $75 million payment... 
From MarketMinute.com Stock News
Why Ionis Pharmaceuticals Inc (IONS), Newell Brands Inc (NWL) and Trina Solar Limited (ADR) (TSL) Are 3 of Today’s Best Stocks
 
Tags NYSE:NWL NASDAQ:BIIB Stock Market Today
From InvestorPlace
Mid-Afternoon Market Update: Trina Solar Gains Following Go-Private Deal; Insperity Shares Drop
Toward the end of trading Monday, the Dow traded down 0.21 percent to 18,392.76 while the NASDAQ gained 0.40 percent to ... 
Tags Global ITEK IONS
From Benzinga
Can You Name This Chart?
So, you think you know the markets? See if you can figure out what stock this is just by looking at this one-year chart (scroll down ... 
Tags Benzinga General BIIB
From Benzinga
15 Biggest Mid-Day Gainers For Monday
TOP SHIPS Inc (NASDAQ: TOPS) shares surged 137 percent to $6.14 following strong earnings report on Friday. The ... 
Tags VZ Intraday Update HRTX
From Benzinga
Mid-Day Market Update: Crude Oil Down 3%; FleetMatics Group Shares Rise Following Acquisition News
Midway through trading Monday, the Dow traded up 0.09 percent to 18,449.30 while the NASDAQ gained 0.64 percent to ... 
Tags FLTX News WLL
From Benzinga
Why Biogen Inc (BIIB) Stock Is Soaring Today
 
Tags Hot Stocks NASDAQ:IONS NASDAQ:BIIB
From InvestorPlace
Noteworthy Monday Option Activity: BIIB, BLDR, SCTY
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Biogen Inc (BIIB), where a total volume of 12,600 contracts has been traded thus... 
Tags Stocks
From Market News Video
Merger news lifts markets
The markets opened higher with the Dow rising 16 points to 18,448 over corporate consolidations. Nasdaq gained 31 points to 5,193. 
Tags Market News
From MarketMinute.com Market Updates
Benzinga's Volume Movers
FleetMatics Group PLC (NYSE: FLTX) surged 38.8 percent to $59.63. The volume of FleetMatics shares traded was 4751 ... 
Tags News FLTX Movers
From Benzinga
Biogen, Ionis shares rally as muscle drug for infants hits its goal
Shares of Biogen and Ionis Pharmaceuticals soared Monday after an interim analysis of late-stage data showed their drug for a deadly muscle disorder in infants met its main goal. 
Tags Biogen Inc Biotechnology Investing
From CNBC.com News
Nasdaq 100 Movers: CTXS, BIIB
In early trading on Monday, shares of Biogen (BIIB) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 5.5%. Year to date, Biogen has lost about 0.1% of its... 
Tags Stocks
From Market News Video
S&P 500 Movers: RIG, BIIB
In early trading on Monday, shares of Biogen (BIIB) topped the list of the day's best performing components of the S&P 500 index, trading up 5.4%. Year to date, Biogen has lost about 0.2% of its... 
Tags Stocks
From Market News Video
Mid-Morning Market Update: Markets Mostly Higher; Tesla To Acquire SolarCity
Following the market opening Monday, the Dow traded down 0.01 percent to 18,431.25 while the NASDAQ gained 0.37 percent ... 
Tags ITEK Global AMRN
From Benzinga
Biogen, Ionis spinal muscular atrophy therapy meets study goal
Companies said nusinersen demonstrated statistically significant improvement in certain motor functions. 
Tags IONS Pharmaceuticals Biotechnology
From MarketWatch
Pharma and tech converge in "fantastic voyage" to fight disease
LONDON, Aug 1 (Reuters) - The line between pharmaceuticals and technology is blurring as companies join forces to tackle chronic diseases using high-tech devices that combine biology, software and... 
Tags companyNews
From Reuters: Company News
15 Stocks Moving In Monday's Pre-Market Session
Gainers FleetMatics Group PLC (NYSE: FLTX) rose 39.3 percent to $59.84 in pre-market trading after Verizon Communications ... 
Tags BIIB Markets Movers & Shakers
From Benzinga
Biogen, Ionis Reveal Nusinersen Meets Primary Endpoint At Interim Analysis Of Final Stage ENDEAR Trial
Biogen Inc. (NASDAQ: BIIB) and Ionis Pharmaceuticals (NASDAQ: IONS) revealed that nusinersen, their investigational treatment for ... 
Tags Biotech News BIIB
From Benzinga
BRIEF-Biogen and Ionis say Nusinersen meets primary endpoint at interim analysis of phase 3 Endear study
* Biogen Inc And Ionis Pharmaceuticals Report Nusinersen Meets Primary Endpoint At Interim Analysis Of Phase 3 Endear Study In Infantile Onset spinal muscular atrophy 
Tags companyNews
From Reuters: Company News
Noteworthy ETF Outflows: BIB, AMGN, CELG, BIIB
Symbols mentioned in this story: BIB, AMGN, CELG, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
RPT-U.S. biotech stocks win back investors in big July run
NEW YORK, July 28 (Reuters) - Biotech returned to the good graces of investors this month and it may be the beginning of a revival for stocks in the industry. 
Tags companyNews
From Reuters: Company News
U.S. biotech stocks win back investors in big July run
NEW YORK, July 28 (Reuters) - Biotech returned to the good graces of investors this month and it may be the beginning of a revival for stocks in the industry. 
Tags companyNews
From Reuters: Company News
Biotech Stocks Strike A Bullish Tone
Biotech stocks continued to drive higher despite the earnings miss in Gilead Sciences and a lackluster overall market. A green screen dominated today with significant upward momentum since the Brexit... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
< Previous 1 2
...
89 90 91 92 93 94 95 96 97
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.